The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Breast Implants and the Risk of Anaplastic Large-Cell Lymphoma in the Breast
Open accessAbstract
IMPORTANCE: Breast implants are among the most commonly used medical devices. Since 2008, the number of women with breast implants diagnosed with anaplastic large-cell lymphoma in the breast (breast-ALCL) has increased, and several reports have suggested an association between breast implants and risk of breast-ALCL. However, relative and absolute risks of breast-ALCL in women with implants are still unknown, precluding evidence-based counseling about implants. OBJECTIVE: To determine relative and absolute risks of breast-ALCL in women with breast implants. DESIGN, SETTING, AND PARTICIPANTS: Through the population-based nationwide Dutch pathology registry we identified all patients diagnosed with primary non-Hodgkin lymphoma in the breast between 1990 and 2016 and retrieved clinical data, including breast implant status, from the treating physicians. We estimated the odds ratio (OR) of ALCL associated with breast implants in a case-control design, comparing implant prevalence between women with breast-ALCL and women with other types of breast lymphoma. Cumulative risk of breast-ALCL was derived from the age-specific prevalence of breast implants in Dutch women, estimated from an examination of 3000 chest x-rays and time trends from implant sales. MAIN OUTCOMES AND MEASURES: Relative and absolute risks of breast-ALCL in women with breast implants. RESULTS: Among 43 patients with breast-ALCL (median age, 59 years), 32 had ipsilateral breast implants, compared with 1 among 146 women with other primary breast lymphomas (OR, 421.8; 95% CI, 52.6-3385.2). Implants among breast-ALCL cases were more often macrotextured (23 macrotextured of 28 total implants of known type, 82%) than expected (49 193 sold macrotextured implants of total sold 109 449 between 2010 and 2015, 45%) based on sales data (P < .001). The estimated prevalence of breast implants in women aged 20 to 70 years was 3.3%. Cumulative risks of breast-ALCL in women with implants were 29 per million at 50 years and 82 per million at 70 years. The number of women with implants needed to cause 1 breast-ALCL case before age 75 years was 6920. CONCLUSIONS AND RELEVANCE: Breast implants are associated with increased risk of breast-ALCL, but the absolute risk remains small. Our results emphasize the need for increased awareness among the public, medical professionals, and regulatory bodies, promotion of alternative cosmetic procedures, and alertness to signs and symptoms of breast-ALCL in women with implants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Swerdlow, S. H., Campo, E., Pileri, S. A., Harris, N. L., Stein, H., Siebert, R., Advani, R., Ghielmini, M., Salles, G. A., Zelenetz, A. D., et al. (2016) · Blood · doi:10.1182/blood-2016-01-643569 · Cited by 7,831
Permutation tests for joinpoint regression with applications to cancer rates
Kim, H.-J., Fay, M. P., Feuer, E. J., & Midthune, D. N. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z · Cited by 6,318
Casparie, M., Tiebosch, A. T. M. G., Burger, G., Blauwgeers, H., van de Pol, A., van Krieken, J. H. J. M., & Meijer, G. A. (2007) · Analytical Cellular Pathology · doi:10.1155/2007/971816 · Cited by 882
Janowsky, E. C., Kupper, L. L., & Hulka, B. S. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003163421105 · Cited by 429
Breast Implant–Associated Anaplastic Large-Cell Lymphoma: Long-Term Follow-Up of 60 Patients
Miranda, R. N., Aladily, T. N., Prince, H. M., Kanagal-Shamanna, R., de Jong, D., Fayad, L. E., Amin, M. B., Haideri, N., Bhagat, G., Brooks, G. S., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.7911 · Cited by 405
Self-citationLoch-Wilkinson, A., Beath, K. J., Knight, R. J. W., Wessels, W. L. F., Magnusson, M., Papadopoulos, T., Connell, T., Lofts, J., Locke, M., Hopper, I., et al. (2017) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000003654 · Cited by 373
Bacterial Biofilm Infection Detected in Breast Implant–Associated Anaplastic Large-Cell Lymphoma
Hu, H., Johani, K., Almatroudi, A., Vickery, K., Van Natta, B., Kadin, M. E., Brody, G., Clemens, M., Cheah, C. Y., Lade, S., et al. (2016) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000002010 · Cited by 348
Khouri, R. K., Rigotti, G., Khouri, R. K., Cardoso, E., Marchi, A., Rotemberg, S. C., Baker, T. J., & Biggs, T. M. (2015) · Plastic and Reconstructive Surgery · doi:10.1097/prs.0000000000001039 · Cited by 187
Kadin, M. E., Deva, A. K., Xu, H., Morgan, J. W., Khare, P. D., MacLeod, R. A. F., Natta, B. W. V., Adams, W. P., Brody, G. S., & Epstein, A. L. (2016) · Aesthetic Surgery Journal · doi:10.1093/asj/sjw023 · Cited by 164
An FDA Viewpoint on Unique Considerations for Medical-Device Clinical Trials
Faris, O., & Shuren, J. E. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1512592 · Cited by 152
Blombery, P. A., Thompson, E. R., Jones, K. L., Arnau, G. M., Lade, S., Markham, J. F., Li, J., Deva, A. K., Johnstone, R. W., Khot, A. S., et al. (2016) · Haematologica · doi:10.3324/haematol.2016.146118 · Cited by 150
Long-Term Health Outcomes in Women With Silicone Gel Breast Implants
Balk, E. M., Earley, A., Avendano, E. E., & Raman, G. (2015) · Annals of Internal Medicine · doi:10.7326/m15-1169 · Cited by 144
Cancer incidence: life table risk versus cumulative risk.
Schouten, L. J., Straatman, H., Kiemeney, L. A. L. M., & Verbeek, A. L. M. (1994) · Journal of Epidemiology & Community Health · doi:10.1136/jech.48.6.596 · Cited by 63
Anaplastic large cell lymphoma (ALCL) and breast implants: Breaking down the evidence
Ye, X., Shokrollahi, K., Rozen, W. M., et al. (2014) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2014.08.002 · Cited by 61
Breast Implant-Associated Anaplastic Large-Cell Lymphoma in a Transgender Woman
de Boer, M., van der Sluis, W. B., de Boer, J. P., Overbeek, L. I. H., van Leeuwen, F. E., Rakhorst, H. A., van der Hulst, R. R. W. J., Hijmering, N. J., Bouman, M., & de Jong, D. (2017) · Aesthetic Surgery Journal · doi:10.1093/asj/sjx098 · Cited by 58
Self-citationMammography in females with an implanted medical device: impact on image quality, pain and anxiety
Paap, E., Witjes, M., van Landsveld-Verhoeven, C., Pijnappel, R. M., Maas, A. H. E. M., & Broeders, M. J. M. (2016) · British Journal of Radiology · doi:10.1259/bjr.20160142 · Cited by 27
Cited by
Clemens, M. W., Jacobsen, E. D., & Horwitz, S. M. (2019) · Aesthetic Surgery Journal · doi:10.1093/asj/sjy331 · Cited by 336
Steenland, K., Schubauer-Berigan, M. K., Vermeulen, R., Lunn, R. M., Straif, K., Zahm, S., Stewart, P., Arroyave, W. D., Mehta, S. S., & Pearce, N. (2020) · Environmental Health Perspectives · doi:10.1289/ehp6980 · Cited by 69
Metadata
- Authors
- de Boer, M., van Leeuwen, F. E., Hauptmann, M., Overbeek, L. I. H., de Boer, J. P., Hijmering, N. J., Sernee, A., Klazen, C. A. H., Lobbes, M. B. I., van der Hulst, R. R. W. J., Rakhorst, H. A., & de Jong, D.
- Venue
- JAMA Oncology
- Publisher
- American Medical Association (AMA)
- Published
- 2018-03-01
- Volume
- 4
- Issue
- 3
- Pages
- 335
- ISSN
- 2374-2437 (ISSN-L)
- OpenAlex
- W2782374784
- Cited by
- 302
- References
- 16
- FWCI
- 46.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.